Fig. 1.

TCGA analysis of immune-related gene expression. a Altered gene expression samples: Total percentage of high-expressing samples demonstrated at left of serially tested immune-related genes in TCGA ovarian serous cystadenocarcinoma study (TCGA, provisional). Red boxes indicate sample with > 1.86 SD expression. b Kaplan–Meier analysis of progression-free survival and overall survival in gene-high as compared to not gene-high samples for respective immune related genes. c LCK mRNA expression levels (RNA Seq V2 RSEM) correlation with LCK protein expression (RPPA). d Mutation count and copy number alterations among total study tumors (blue) and LCK-high tumors (red). e Kaplan–Meier analysis of progression-free survival and overall survival in LCK high (red) tumors compared to non-LCK high (blue)